bortezomib accord 2,5 mg/ml
accord healthcare polska sp. z o.o. - polonia - bortezomibum - sol. inj. - 2,5mg/ml - alte antineoplazice inhibitori de proteazom
bortezomib accord 3,5 mg
accord healthcare polska sp.z o.o - polonia - bortezomibum - pulb. pt. sol. inj. - 3,5mg - alte antineoplazice inhibitori de proteazom
bortezomib fresenius kabi 2,5 mg
fresenius kabi deutschland gmbh - germania - bortezomibum - pulb. pt. sol. inj. - 2,5mg - alte antineoplazice inhibitori de proteazom
bortezomib fresenius kabi 3,5 mg
fresenius kabi deutschland gmbh - germania - bortezomibum - pulb. pt. sol. inj. - 3,5mg - alte antineoplazice inhibitori de proteazom
bortezomib hospira 3,5 mg
pfizer service company bvba - belgia - bortezomibum - pulb. pt. sol. inj. - 3,5mg - alte antineoplazice inhibitori de proteazom
bortezomib sandoz 2,5 mg
synthon hispania sl - spania - bortezomibum - pulb. pt. sol. inj. - 2,5mg - alte antineoplazice inhibitori de proteazom
bortezomib sun 3,5 mg
sun pharmaceutical industries europe b.v. - olanda - bortezomibum - pulb. pt. sol. inj. - 3,5mg - alte antineoplazice inhibitori de proteazom
velcade 1 mg
janssen pharmaceutica nv - belgia - bortezomibum - pulb. pt. sol. inj. - 1mg - alte antineoplazice inhibitori de proteazom
velcade 3,5 mg
janssen pharmaceutica nv - belgia - bortezomibum - pulb. pt. sol. inj. - 3,5mg - alte antineoplazice inhibitori de proteazom